Identification of Missing Carbon Fixation Enzymes as Potential Drug Targets in Mycobacterium Tuberculosis

A Katiyar, H Singh, KK Azad - Journal of integrative bioinformatics, 2018 - degruyter.com
Metabolic adaptation to the host environment has been recognized as an essential
mechanism of pathogenicity and the growth of Mycobacterium tuberculosis (Mtb) in the …

Metabolomics of Central Carbon Metabolism in Mycobacterium tuberculosis

AD Baughn, KY Rhee - Molecular Genetics of Mycobacteria, 2014 - Wiley Online Library
Central carbon metabolism (CCM)—defined as the enzymatic transformation of carbon
through glycolysis, the pentose phosphate pathway (PPP), the citric acid cycle, the …

High quality genome-scale metabolic network reconstruction of mycobacterium tuberculosis and comparison with human metabolic network: application for drug …

S Kalapanulak - 2009 - era.ed.ac.uk
Mycobacterium tuberculosis (Mtb), a pathogenic bacterium, is the causative agent in the vast
majority of human tuberculosis (TB) cases. Nearly one-third of the world's population has …

Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ 661 and proposing alternative drug targets

N Jamshidi, BØ Palsson - BMC systems biology, 2007 - Springer
Background: Mycobacterium tuberculosis continues to be a major pathogen in the third
world, killing almost 2 million people a year by the most recent estimates. Even in …

Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets

R Vashisht, AG Bhat, S Kushwaha, A Bhardwaj… - Journal of Translational …, 2014 - Springer
Background The effectiveness of current therapeutic regimens for Mycobacterium
tuberculosis (Mtb) is diminished by the need for prolonged therapy and the rise of drug …

Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis

S Anishetty, M Pulimi, G Pennathur - Computational biology and chemistry, 2005 - Elsevier
The emergence of multidrug resistant varieties of Mycobacterium tuberculosis has led to a
search for novel drug targets. We have performed an insilico comparative analysis of …

Bioinformatics Analysis to Uncover the Potential Drug Targets Responsible for Mycobacterium tuberculosis Peptidoglycan and Lysine Biosynthesis

D Ayu Eka Pitaloka, A Izzati… - … and Biology Insights, 2023 - journals.sagepub.com
Drug-resistant tuberculosis (TB), which results mainly from the selection of naturally resistant
strains of Mycobacterium tuberculosis (MTB) due to mismanaged treatment, poses a severe …

Integrated gene co-expression network analysis in the growth phase of Mycobacterium tuberculosis reveals new potential drug targets

BL Puniya, D Kulshreshtha, SP Verma, S Kumar… - Molecular …, 2013 - pubs.rsc.org
We have carried out weighted gene co-expression network analysis of Mycobacterium
tuberculosis to gain insights into gene expression architecture during log phase growth. The …

[HTML][HTML] High-Throughput Screen for Cell Wall Synthesis Network Module in Mycobacterium tuberculosis Based on Integrated Bioinformatics Strategy

X Luo, J Pan, Q Meng, J Huang, W Wang… - … in Bioengineering and …, 2020 - frontiersin.org
Background Mycobacterium tuberculosis is one of the deadliest pathogens in humans. Co-
infection of M. tuberculosis with HIV and the emergence of multi-drug-resistant tuberculosis …

Metabolic adaptation of two in silico mutants of Mycobacterium tuberculosis during infection

VA López-Agudelo, A Baena, H Ramirez-Malule… - BMC Systems …, 2017 - Springer
Abstract Background Up to date, Mycobacterium tuberculosis (Mtb) remains as the worst
intracellular killer pathogen. To establish infection, inside the granuloma, Mtb reprograms its …